<VariationArchive VariationID="39727" VariationName="NM_000431.4(MVK):c.417dup (p.Gly140fs)" VariationType="Duplication" Accession="VCV000039727" Version="5" RecordType="classified" NumberOfSubmissions="4" NumberOfSubmitters="3" DateLastUpdated="2024-06-23" DateCreated="2014-02-20" MostRecentSubmission="2022-06-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="48326" VariationID="39727">
      <GeneList>
        <Gene Symbol="MVK" FullName="mevalonate kinase" GeneID="4598" HGNC_ID="HGNC:7530" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>12q24.11</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="109573272" stop="109598125" display_start="109573272" display_stop="109598125" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="110011499" stop="110035070" display_start="110011499" display_stop="110035070" Strand="+" />
          </Location>
          <OMIM>251170</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000431.4(MVK):c.417dup (p.Gly140fs)</Name>
      <CanonicalSPDI>NC_000012.12:109581434:CCCCCC:CCCCCCC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>12q24.11</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="109581434" stop="109581435" display_start="109581434" display_stop="109581435" variantLength="1" positionVCF="109581434" referenceAlleleVCF="G" alternateAlleleVCF="GC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="110019239" stop="110019240" display_start="110019239" display_stop="110019240" variantLength="1" positionVCF="110019239" referenceAlleleVCF="G" alternateAlleleVCF="GC" />
      </Location>
      <ProteinChange>G140fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000431.2" sequenceAccession="NM_000431" sequenceVersion="2" change="c.417dupC">
            <Expression>NM_000431.2:c.417dupC</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_156t1" sequenceAccession="LRG_156t1" change="c.417dup">
            <Expression>LRG_156t1:c.417dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_156" sequenceAccession="LRG_156" change="g.12746dup">
            <Expression>LRG_156:g.12746dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.11" sequenceAccession="NC_000012" sequenceVersion="11" change="g.110019245dup" Assembly="GRCh37">
            <Expression>NC_000012.11:g.110019245dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.12" sequenceAccession="NC_000012" sequenceVersion="12" change="g.109581440dup" Assembly="GRCh38">
            <Expression>NC_000012.12:g.109581440dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007702.1" sequenceAccession="NG_007702" sequenceVersion="1" change="g.12746dup">
            <Expression>NG_007702.1:g.12746dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000431.4" sequenceAccession="NM_000431" sequenceVersion="4" change="c.417dup" MANESelect="true">
            <Expression>NM_000431.4:c.417dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000422.1" sequenceAccession="NP_000422" sequenceVersion="1" change="p.Gly140fs">
            <Expression>NP_000422.1:p.Gly140fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001114185.3" sequenceAccession="NM_001114185" sequenceVersion="3" change="c.417dup">
            <Expression>NM_001114185.3:c.417dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001107657.1" sequenceAccession="NP_001107657" sequenceVersion="1" change="p.Gly140fs">
            <Expression>NP_001107657.1:p.Gly140fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001301182.2" sequenceAccession="NM_001301182" sequenceVersion="2" change="c.371+1494dup">
            <Expression>NM_001301182.2:c.371+1494dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA130492" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="251170.0012" DB="OMIM" />
        <XRef Type="rs" ID="104895373" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000431.4(MVK):c.417dup (p.Gly140fs) AND Mevalonic aciduria" Accession="RCV000032941" Version="29">
        <ClassifiedConditionList TraitSetID="3234">
          <ClassifiedCondition DB="MedGen" ID="C1959626">Mevalonic aciduria</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2012-10-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000431.4(MVK):c.417dup (p.Gly140fs) AND Hyperimmunoglobulin D with periodic fever" Accession="RCV000083840" Version="2">
        <ClassifiedConditionList TraitSetID="3235">
          <ClassifiedCondition DB="MedGen" ID="C0398691">Hyperimmunoglobulin D with periodic fever</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no classification provided</ReviewStatus>
            <Description SubmissionCount="1">not provided</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000431.4(MVK):c.417dup (p.Gly140fs) AND Porokeratosis 3, disseminated superficial actinic type" Accession="RCV000074423" Version="23">
        <ClassifiedConditionList TraitSetID="223">
          <ClassifiedCondition DB="MedGen" ID="C1867981">Porokeratosis 3, disseminated superficial actinic type</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2012-10-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000431.4(MVK):c.417dup (p.Gly140fs) AND not provided" Accession="RCV000657168" Version="2">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-11-08" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-11-08" NumberOfSubmissions="4" NumberOfSubmitters="3" DateCreated="2014-02-20" MostRecentSubmission="2022-06-09">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16835861</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22983302</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="223" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="3521" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Porokeratosis 3, disseminated superficial actinic type</ElementValue>
                <XRef ID="MONDO:0008293" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Porokeratosis, disseminated superficial actinic 1</ElementValue>
                <XRef ID="Porokeratosis%2C+disseminated+superficial+actinic+1/5877" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">POROKERATOSIS 3, MULTIPLE TYPES</ElementValue>
                <XRef Type="MIM" ID="175900" DB="OMIM" />
                <XRef Type="Allelic variant" ID="251170.0019" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">POROKERATOSIS 3, MIBELLI TYPE</ElementValue>
                <XRef Type="Allelic variant" ID="251170.0018" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">DSAP1</ElementValue>
                <XRef Type="MIM" ID="175900" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">DSAP</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">POROK3</ElementValue>
                <XRef Type="MIM" ID="175900" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9505" />
                <XRef ID="9505" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="C1867981" DB="MedGen" />
              <XRef ID="MONDO:0008293" DB="MONDO" />
              <XRef Type="MIM" ID="175900" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3234" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="2917" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Mevalonic aciduria</ElementValue>
                <XRef ID="Mevalonic+aciduria/4722" DB="Genetic Alliance" />
                <XRef ID="MONDO:0012481" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MEVA</ElementValue>
                <XRef Type="MIM" ID="610377" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3588" />
                <XRef ID="3588" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="general" Abbrev="EMQN, 2012">
                <ID Source="PubMed">22661645</ID>
                <ID Source="pmc">3500529</ID>
              </Citation>
              <XRef ID="29" DB="Orphanet" />
              <XRef ID="C1959626" DB="MedGen" />
              <XRef ID="MONDO:0012481" DB="MONDO" />
              <XRef Type="MIM" ID="610377" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3235" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="5276" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hyperimmunoglobulin D with periodic fever</ElementValue>
                <XRef ID="Hyper-IgD+syndrome/3534" DB="Genetic Alliance" />
                <XRef ID="234538002" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hyperimmunoglobulinemia D and periodic fever syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Periodic fever Dutch type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hyperimmunoglobulinemia D with periodic fever</ElementValue>
                <XRef ID="MONDO:0009849" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hyperimmunoglobulinemia D</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">HIDS</ElementValue>
                <XRef Type="MIM" ID="260920" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2788" />
                <XRef ID="2788" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="343" DB="Orphanet" />
              <XRef ID="C0398691" DB="MedGen" />
              <XRef ID="MONDO:0009849" DB="MONDO" />
              <XRef Type="MIM" ID="260920" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="203745" SubmissionDate="2010-06-07" DateLastUpdated="2014-02-20" DateCreated="2014-02-20">
        <ClinVarSubmissionID localKey="543" />
        <ClinVarAccession Accession="SCV000115942" DateUpdated="2014-02-20" DateCreated="2014-02-20" Type="SCV" Version="1" SubmitterName="Unité médicale des maladies autoinflammatoires, CHRU Montpellier" OrgID="500314" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <MethodType>not provided</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000431.1:c.417dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Hyperimmunoglobulin D with periodic fever</ElementValue>
            </Name>
            <XRef DB="OMIM" ID="260920" Type="MIM" />
          </Trait>
        </TraitSet>
        <Comment>also involved in OMIM 25117</Comment>
        <SubmissionNameList>
          <SubmissionName>BATCH_FIRST_Initial_rs_request</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="183632" SubmissionDate="2022-06-02" DateLastUpdated="2022-06-09" DateCreated="2013-11-28">
        <ClinVarSubmissionID localKey="251170.0012_POROKERATOSIS 3, DISSEMINATED SUPERFICIAL ACTINIC TYPE" title="MVK, 1-BP INS, 417C_POROKERATOSIS 3, DISSEMINATED SUPERFICIAL ACTINIC TYPE" />
        <ClinVarAccession Accession="SCV000108439" DateUpdated="2022-06-09" DateCreated="2013-11-28" Type="SCV" Version="7" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2012-10-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to included disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Mevalonic Aciduria</Attribute>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In a patient with mevalonic aciduria (MEVA; 610377), Mandey et al. (2006) identified a 1-bp insertion (417insC) in exon 5 of the MVK gene, resulting in a frameshift and premature termination (Gly140fs). It was not clear from this paper whether the patient was homozygous for the mutation or carried a second MVK mutation on the other allele.</Attribute>
              <Citation>
                <ID Source="PubMed">16835861</ID>
              </Citation>
              <XRef DB="OMIM" ID="610377" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Porokeratosis 3</Attribute>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Zhang et al. (2012) identified a heterozygous 417insC mutation, resulting in premature termination (Gly140ArgfsTer47), in a Chinese patient with sporadic occurrence of disseminated superficial actinic porokeratosis (POROK3; 175900). This patient had no clinical features of mevalonic aciduria.</Attribute>
              <Citation>
                <ID Source="PubMed">22983302</ID>
              </Citation>
              <XRef DB="OMIM" ID="175900" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MVK" />
          </GeneList>
          <Name>MVK, 1-BP INS, 417C</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP INS, 417C</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="251170.0012" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="included">POROKERATOSIS 3, DISSEMINATED SUPERFICIAL ACTINIC TYPE</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="93916" SubmissionDate="2022-06-02" DateLastUpdated="2022-06-09" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="251170.0012_MEVALONIC ACIDURIA" title="MVK, 1-BP INS, 417C_MEVALONIC ACIDURIA" />
        <ClinVarAccession Accession="SCV000056713" DateUpdated="2022-06-09" DateCreated="2013-04-04" Type="SCV" Version="8" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2012-10-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Mevalonic Aciduria</Attribute>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In a patient with mevalonic aciduria (MEVA; 610377), Mandey et al. (2006) identified a 1-bp insertion (417insC) in exon 5 of the MVK gene, resulting in a frameshift and premature termination (Gly140fs). It was not clear from this paper whether the patient was homozygous for the mutation or carried a second MVK mutation on the other allele.</Attribute>
              <Citation>
                <ID Source="PubMed">16835861</ID>
              </Citation>
              <XRef DB="OMIM" ID="610377" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Porokeratosis 3</Attribute>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Zhang et al. (2012) identified a heterozygous 417insC mutation, resulting in premature termination (Gly140ArgfsTer47), in a Chinese patient with sporadic occurrence of disseminated superficial actinic porokeratosis (POROK3; 175900). This patient had no clinical features of mevalonic aciduria.</Attribute>
              <Citation>
                <ID Source="PubMed">22983302</ID>
              </Citation>
              <XRef DB="OMIM" ID="175900" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MVK" />
          </GeneList>
          <Name>MVK, 1-BP INS, 417C</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP INS, 417C</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="251170.0012" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">MEVALONIC ACIDURIA</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1518849" SubmissionDate="2021-09-24" DateLastUpdated="2018-07-09" DateCreated="2018-07-09">
        <ClinVarSubmissionID localKey="GDXSV:152009" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV000778888" DateUpdated="2018-07-09" DateCreated="2018-07-09" Type="SCV" Version="2" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" OrgAbbreviation="GDX" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-11-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed in large population cohorts (Lek et al., 2016); This variant is associated with the following publications: (PMID: 22983302, 16835861, 24716072, 31980526, 31589614)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MVK" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:41014</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000431.2:c.417dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_50_20210924044205</SubmissionName>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="183632" TraitType="Disease" MappingType="Name" MappingValue="POROKERATOSIS 3, DISSEMINATED SUPERFICIAL ACTINIC TYPE" MappingRef="Alternate">
        <MedGen CUI="C2676769" Name="Porokeratosis 5, disseminated superficial actinic type" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="203745" TraitType="Disease" MappingType="Name" MappingValue="Hyperimmunoglobulin D with periodic fever" MappingRef="Preferred">
        <MedGen CUI="C0398691" Name="Hyperimmunoglobulin D with periodic fever" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1518849" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="93916" TraitType="Disease" MappingType="Name" MappingValue="MEVALONIC ACIDURIA" MappingRef="Preferred">
        <MedGen CUI="C1959626" Name="Mevalonic aciduria" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

